These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 29568392)
1. MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2. Chen MJ; Wu DW; Wang GC; Wang YC; Chen CY; Lee H Oncotarget; 2018 Mar; 9(17):13758-13767. PubMed ID: 29568392 [TBL] [Abstract][Full Text] [Related]
2. Association of cytoplasmic p27 expression with an unfavorable response to cisplatin-based chemotherapy and poor outcomes in non-small cell lung cancer. Lin TC; Tsai LH; Chou MC; Chen CY; Lee H Tumour Biol; 2016 Mar; 37(3):4017-23. PubMed ID: 26482622 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA 192 regulates chemo-resistance of lung adenocarcinoma for gemcitabine and cisplatin combined therapy by targeting Bcl-2. Cao J; He Y; Liu HQ; Wang SB; Zhao BC; Cheng YS Int J Clin Exp Med; 2015; 8(8):12397-403. PubMed ID: 26550150 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-218 regulates cisplatin (DPP) chemosensitivity in non-small cell lung cancer by targeting RUNX2. Xie J; Yu F; Li D; Zhu X; Zhang X; Lv Z Tumour Biol; 2016 Jan; 37(1):1197-204. PubMed ID: 26282001 [TBL] [Abstract][Full Text] [Related]
5. Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2. Tung MC; Lin PL; Wang YC; He TY; Lee MC; Yeh SD; Chen CY; Lee H Oncotarget; 2015 Dec; 6(39):41692-705. PubMed ID: 26497680 [TBL] [Abstract][Full Text] [Related]
6. miR-107 regulates cisplatin chemosensitivity of A549 non small cell lung cancer cell line by targeting cyclin dependent kinase 8. Zhang Z; Zhang L; Yin ZY; Fan XL; Hu B; Wang LQ; Zhang D Int J Clin Exp Pathol; 2014; 7(10):7236-41. PubMed ID: 25400821 [TBL] [Abstract][Full Text] [Related]
7. miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression. Sui C; Meng F; Li Y; Jiang Y J Transl Med; 2015 Apr; 13():132. PubMed ID: 25927928 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin. Zhang X; Zhang Y; Liu X; Fang A; Li P; Li Z; Liu T; Yang Y; Du L; Wang C PLoS One; 2015; 10(11):e0143441. PubMed ID: 26599571 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-101 contributes to epithelial-mesenchymal transition in cisplatin resistance of NSCLC cells by targeting ROCK2. Ye Z; Yin S; Su Z; Bai M; Zhang H; Hei Z; Cai S Oncotarget; 2016 Jun; 7(25):37524-37535. PubMed ID: 27229528 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc. Lin TC; Lin PL; Cheng YW; Wu TC; Chou MC; Chen CY; Lee H Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1532-9. PubMed ID: 25990966 [TBL] [Abstract][Full Text] [Related]
12. Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study. Berghmans T; Ameye L; Willems L; Paesmans M; Mascaux C; Lafitte JJ; Meert AP; Scherpereel A; Cortot AB; Cstoth I; Dernies T; Toussaint L; Leclercq N; Sculier JP; Lung Cancer; 2013 Nov; 82(2):340-5. PubMed ID: 24007627 [TBL] [Abstract][Full Text] [Related]
13. miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy. Wang F; Lou JF; Cao Y; Shi XH; Wang P; Xu J; Xie EF; Xu T; Sun RH; Rao JY; Huang PW; Pan SY; Wang H Exp Mol Med; 2015 May; 47(5):e162. PubMed ID: 25952770 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line. Li JH; Luo N; Zhong MZ; Xiao ZQ; Wang JX; Yao XY; Peng Y; Cao J Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998 [TBL] [Abstract][Full Text] [Related]
15. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2. Qiu T; Zhou L; Wang T; Xu J; Wang J; Chen W; Zhou X; Huang Z; Zhu W; Shu Y; Liu P Int J Mol Med; 2013 Sep; 32(3):593-8. PubMed ID: 23856992 [TBL] [Abstract][Full Text] [Related]
16. Effect of miR-1244 on cisplatin-treated non-small cell lung cancer via MEF2D expression. Li GJ; Zhao GQ; Yang JP; Zhou YC; Yang KY; Lei YJ; Huang YC Oncol Rep; 2017 Jun; 37(6):3475-3483. PubMed ID: 28498474 [TBL] [Abstract][Full Text] [Related]
17. miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1. Zhang H; Hu B; Wang Z; Zhang F; Wei H; Li L Cancer Chemother Pharmacol; 2017 Nov; 80(5):973-984. PubMed ID: 28956120 [TBL] [Abstract][Full Text] [Related]
18. MiR-129-5p inhibits non-small cell lung cancer cell stemness and chemoresistance through targeting DLK1. Ma Z; Cai H; Zhang Y; Chang L; Cui Y Biochem Biophys Res Commun; 2017 Aug; 490(2):309-316. PubMed ID: 28619508 [TBL] [Abstract][Full Text] [Related]
19. MnSOD overexpression confers cisplatin resistance in lung adenocarcinoma via the NF-κB/Snail/Bcl-2 pathway. Chen PM; Cheng YW; Wu TC; Chen CY; Lee H Free Radic Biol Med; 2015 Feb; 79():127-37. PubMed ID: 25499851 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of miR-216b sensitizes NSCLC cells to cisplatin-induced apoptosis by targeting c-Jun. Huang G; Pan J; Ye Z; Fang B; Cheng W; Cao Z Oncotarget; 2017 Nov; 8(61):104206-104215. PubMed ID: 29262633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]